Chris Calabrese | Investor Relations |
Steven Shallcross | Chief Executive & Chief Financial Officer |
Manel Cascallo | General Director of VCN & European Operations |
Laura Suriel | Alliance Global Partners |
Michael Okunewitch | Maxim Group |
Good day, and welcome to the Synthetic Biologics' Second Quarter 2022 Earnings Call. Today's conference is being recorded. And at this time, I'd like to turn the conference over to Chris Calabrese. Please go ahead sir.
Thank you, operator and good morning, everyone.